Managers / Q2 2024 · view latest →

Orion Investment Co

CIK 0002033920 · 7800 FORSYTH BLVD. SUITE 820, ST. LOUIS, MO, 63105 · 314-725-3800

Reported Value

$251M

Q2 2024

Positions

Filings on Record

2019–present window

Filed

Aug 15, 2024

original filing

Summary

Orion Investment Co reported $251M in U.S.-listed holdings across 64 positions for Q2 2024.

Its largest position, MSFT, represents 18.7% of the portfolio.

Portfolio Metrics

Top-10 Concentration

+65.6%

share of reported value

Largest Position

+18.7%

Microsoft

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value

Portfolio Composition

By security type

Common Stock · 98.8% · $248M
Other · 1.0% · $2M
ADR · 0.2% · $577,801

Quarter-over-Quarter Changes full breakdown →

Issuer	Move	Share Δ	Shares now	Value Δ	Value now
MSFT Microsoft Corp	NEW	+105.3K	105.3K	+$47M	$47M
REGN Regeneron Pharmaceuticals	NEW	+29.5K	29.5K	+$31M	$31M
QCOM Qualcomm Inc	NEW	+120.2K	120.2K	+$24M	$24M
2655787D Blueprint Medicines Corp	NEW	+108.8K	108.8K	+$12M	$12M
ISI Ionis Pharmaceuticals Inc	NEW	+218.6K	218.6K	+$10M	$10M
EXMOC Exxon Mobil Corp	NEW	+83.1K	83.1K	+$10M	$10M
PG Procter And Gamble Co	NEW	+57.7K	57.7K	+$10M	$10M
BIIB Biogen Inc	NEW	+32.6K	32.6K	+$8M	$8M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

49 positions

Export to Excel

#	Issuer	Class	% Portfolio	Value ↓	Shares
1	MSFT Microsoft Corp history →	COM	18.75%	$47M	105.3K
2	REGN Regeneron Pharmaceuticals history →	COM	12.35%	$31M	29.5K
3	QCOM Qualcomm Inc history →	COM	9.53%	$24M	120.2K
4	2655787D Blueprint Medicines Corp history →	COM	4.67%	$12M	108.8K
5	ISI Ionis Pharmaceuticals Inc history →	COM	4.15%	$10M	218.6K
6	EXMOC Exxon Mobil Corp history →	COM	3.81%	$10M	83.1K
7	PG Procter And Gamble Co history →	COM	3.79%	$10M	57.7K
8	BIIB Biogen Inc history →	COM	3.01%	$8M	32.6K
9	ABT Abbott Labs history →	COM	2.81%	$7M	67.8K
10	PH Parker-Hannifin Corp history →	COM	2.77%	$7M	13.8K
11	NEE Nextera Energy Inc history →	COM	2.71%	$7M	96.1K
12	IOVA Iovance Biotherapeutics Inc history →	COM	2.54%	$6M	794.7K
13	HSY Hershey Co history →	COM	2.44%	$6M	33.4K
14	CMI Cummins Inc history →	COM	2.39%	$6M	21.7K
15	GD General Dynamics Corp history →	COM	2.31%	$6M	20.0K
16	INTC Intel Corp history →	COM	1.83%	$5M	148.1K
17	CNR Canadian Natl Ry Co history →	COM	1.63%	$4M	34.7K
18	HII Huntington Ingalls Inds Inc history →	COM	1.29%	$3M	13.2K
19	AAPL Apple Inc history →	COM	1.16%	$3M	13.8K
20	MRK Merck & Co history →	COM	1.08%	$3M	22.0K
21	PLTR Palantir Technologies Inc history →	CL A	1.05%	$3M	104.1K
22	SHOP Shopify Inc	CL A	0.97%	$2M	36.9K
23	CCO Cameco Corp	COM	0.90%	$2M	45.9K
24	ASML Holding N V	N Y REGISTRY SHS	0.90%	$2M	2.2K
25	EFX Equifax Inc	COM	0.86%	$2M	8.9K
26	ATO Atmos Energy Corp	COM	0.74%	$2M	15.9K
27	RGLD Royal Gold Inc	COM	0.65%	$2M	13.1K
28	CDNS Cadence Design Systems Inc	COM	0.64%	$2M	5.2K
29	IONQ IonQ Inc	COM	0.54%	$1M	194.1K
30	GOOGL Alphabet Inc Cl A	CAP STK CL A · CAP STK CL C	0.48%	$1M	6.6K
31	PANW Palo Alto Networks Inc	COM	0.46%	$1M	3.4K
32	SR Spire Inc	COM	0.44%	$1M	18.4K
33	BMY Bristol-Myers Squibb Co	COM	0.42%	$1M	25.4K
34	EMR Emerson Elec Co	COM	0.40%	$1M	9.2K
35	AEE Ameren Corp	COM	0.40%	$1M	14.2K
36	ABBV Abbvie Inc	COM	0.39%	$991,043	5.8K
37	IBOC International Business Machs	COM	0.39%	$970,249	5.6K
38	AMZN Amazon Com Inc	COM	0.34%	$851,266	4.4K
39	JNJ Johnson & Johnson	COM	0.29%	$726,823	5.0K
40	CBSH Commerce Bancshares Inc	COM	0.24%	$597,292	10.7K
41	SHEL Shell Plc	SPON ADS	0.23%	$577,801	8.0K
42	UNH UnitedHealth Group Inc	COM	0.22%	$560,186	1.1K
43	PYPL Paypal Hldgs Inc	COM	0.21%	$526,274	9.1K
44	MCX McCormick & Co Inc	COM NON VTG	0.21%	$514,670	7.3K
45	SO Southern Co	COM	0.20%	$499,163	6.4K
46	NEM Newmont Corporation	COM	0.20%	$496,201	11.9K
47	PFE Pfizer	COM	0.19%	$467,266	16.7K
48	BRK/B Berkshire Hathaway Inc Del	CL B NEW	0.17%	$427,140	1.1K
49	LLY Eli Lilly & Co	COM	0.17%	$418,286	462

Filing History

Quarter	Reported Value	Positions	Filed	Type	Links
Q1 2026	$315M	69	May 12, 2026	13F-HR	changes · EDGAR ↗
Q4 2025	$328M	68	Feb 11, 2026	13F-HR	changes · EDGAR ↗
Q3 2025	$315M	70	Nov 13, 2025	13F-HR	changes · EDGAR ↗
Q2 2025	$282M	70	Aug 14, 2025	13F-HR	changes · EDGAR ↗
Q1 2025	$245M	68	May 14, 2025	13F-HR	changes · EDGAR ↗
Q4 2024	$251M	65	Feb 13, 2025	13F-HR	changes · EDGAR ↗
Q3 2024	$257M	66	Nov 13, 2024	13F-HR	changes · EDGAR ↗
Q2 2024	$251M	64	Aug 15, 2024	13F-HR	changes · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.